Genomics & Bioinformatics

Using the latest next-generation sequencing technology and bioinformatics methods to sequence and analyse the genomes and transcriptomes of human breast cancers.

Bioinformatics, sequence assembly, transcriptomics, gene regulation networks, high throughput informatics for big data. Birol Lab is located at British Columbia Cancer Agency, Genome Sciences Centre.

High throughput data analysis, data standards, flow cytomety, GvHD biomarker identification, cluster identification.

Genetics of human cancer susceptibility, particularly lymphoma, and genetics of healthy aging and longevity. Family and population-based genetics studies. We use techniques such as genotyping and exome and whole genome sequencing.

Vesicle trafficking, lipid transport, yeast genetics, functional genomics, and mammalian cell biology.

Human pedigree and population genetics, and mouse modeling of neurodegenerative disease – designed to inform therapeutic development.

Neurological mutant mice are used as entrees into studying the genetics, cell biology and development of genes that are critical to nervous system development.

Mammalian development, Transcriptional regulation and epigenetics, Hepatocyte differentiation, Heart valve formation, Signal transduction, Transgenic/knockout mice, Whole genome profiling

Bioinformatics, gene expression, gene regulation, genome sequence analysis and genome assembly.

Our research bridges the molecular mechanisms of epigenetic regulation with the social and environmental determinants of human health to develop a comprehensive understanding of biological embedding of early life experiences

Stem cells, developmental control, telomere biology, self-renewal and genetic instability.

Discovery of monogenic causes of human developmental or metabolic disorders; natural history of monogenic disorders; optimal management of mitochondrial disorders.

Interplay between transcription, DNA methylation and histone modifications in the germ line, early development and disease

Gene regulatory changes in malignancy, ribosomal variation in cancer, impact of transposable elements on mammalian genes.

Genomics, bioinformatics, cancer biology, genetics, epigenetics

Proteomics, protein-protein interactions, protein isoform function, alternative splicing.

The immune response to cancer; development of immunotherapies targeting the cancer genome.

Chromosomal etiology of intellectual disability/autism and cancer, Molecular cytogenetics, Identification of subtle chromosomal abnormalities using whole genome arrays

Genetics and epigenetics of human reproduction. Environmental effects on genes affecting placental function and fetal development. Epigenomics related to preeclampsia, intrauterine growth restriction, birth defects and early child development.

Pharmacogenomics of adverse drug reactions, genomics, personalized medicine.

1) Scope and impact of germline findings identified in next generation sequencing and the use of these technologies in oncology; 2) molecular diagnosis and characterization of hereditary cancer syndromes

Gene-based therapies for diseases of the brain and eye, cell-type specific MiniPomoters for rAAV delivery of gene augmentation and genome editing (CRISPR/cas9) therapies to cure mouse models of the human disease.

We study how transcriptional regulation affects metabolism and stress responses in C. elegans (worm), mice, and mammalian cells, to identify mechanisms that can be targeted in diseases such as cancers, diabetes, and neurodegenerative disorders.

Computational analysis of human genome sequence for the study of gene regulation and rare pediatric disorders.